This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Northern Centre For Cancer Care Acquires Two TrueBeam™ Devices From Varian Medical Systems To Deliver Advanced Radiosurgery Treatments

Stocks in this article: VAR

NEWCASTLE-UPON-TYNE, UK, Nov. 29, 2012 /PRNewswire/ -- Cancer patients in the north-east of England will be able to receive modern radiosurgery treatments without having to travel for up to two hours for treatments. The Northern Centre for Cancer Care (NCCC) at the Freeman Hospital in Newcastle-upon-Tyne is acquiring two TrueBeam™ STx medical linear accelerators from Varian Medical Systems (NYSE: VAR) to begin offering advanced stereotactic radiosurgery treatments for the first time.

The NCCC, currently equipped with eight linear accelerators from Siemens, intends to replace its older machines over time and earlier this autumn placed orders for two TrueBeam STx machines which are capable of the full range of modern radiotherapy treatments, including advanced radiosurgery. The machines are slated to be installed at the center in 2013.

"We want to introduce stereotactic ablative body radiotherapy (SABR) and stereotactic radiosurgery (SRS) programs, which are becoming the standard of care for many cancer treatments," says Gill Lawrence, head of radiotherapy physics. "Once the new machines are installed, the SABR program will be available initially for lung cancer patients the SRS program for treating conditions in the brain; subsequent developments include plans for liver and pancreatic cancer treatments." SABR is offering early-stage non-small-cell lung cancer patients - including those who are inoperable or elderly - a non-invasive treatment option.

The NCCC currently refers stereotactic patients to cancer centers in Clatterbridge, Sheffield or Leeds, requiring either a daily two-hour journey for treatments or overnight stays. "It will be a great relief for patients and staff to be able to offer equivalent treatments here in Newcastle," says Susan Lamb, radiotherapy services manager.

Dr. Ian Pedley, consultant oncologist at the NCCC, said the hospital decided to install two TrueBeam STx devices because of Varian's experience in radiosurgery technology and its focus on an integrated approach. "We wanted to be able to get up and running quickly and use the new machines for all treatments, not just stereotactic," said Dr. Pedley. "We will be treating a lot of patients on these machines and workflow is extremely important to us."

The Northern Centre for Cancer Care, which moved to a new purpose-built oncology center in 2008, serves 1.7 million people from across the Northumberland, Tyne-and-Wear and Durham region. The clinic aims to deliver 38 to 42 individual treatments per day on each of its eight linear accelerators.

Newcastle-based charities, including the local Charlie Bear Fund and the Sir Bobby Robson Foundation – initiated by the former England and Newcastle soccer team manager – were instrumental in contributing to the purchase of the new machines.      

Varian's TrueBeam platform, introduced in 2010, offers a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. With its High Intensity Mode, TrueBeam devices can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of technology.  The TrueBeam STx is a high-end model optimized for radiosurgical applications, where very large doses are delivered in a single treatment or only a few sessions.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs